Progress on US FDA's White Oak Federal Research Center

15 January 2009

The US Food and Drug Administration has dedicated a seventh new building at the White Oak Federal Research Center in Silver Spring, Maryland, as  part of the agency consolidation project on the campus, to accommodate  portions of the FDA's Commissioner and related executive functions.

Discussing the new building on his weekly blog, outgoing Commissioner  Andrew von Eshenbach said "that what may look like construction of new  buildings is actually the creation of a new future - a new future in  the regulation of drugs, medical devices, vaccines and other  FDA-regulated products that will save lives because of a modern, strong  and efficient FDA. This campus is not merely a collection of offices and  laboratories, but the creation of a critical mass of intellectual  ability, incredible energy, and unparalleled dedication on the part of  FDA scientists and experts that now have a new home at White Oak. During  2008, the number of FDA staff at White Oak Campus has grown to over  3,000. By 2012, there will be as many as 8,000 FDA employees working on  this consolidated campus."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight